Einama Takahiro 永生高広

Researcher Number	70421964
Affiliation (Current)	2025: 防衛医科大学校(医学教育部医学科進学課程及び専門課程、動物実験施設、共同利用研究施設、病院並びに防衛, 外科学, 講師
Affiliation (based on the past Project Information) *help	2020 – 2023: 防衛医科大学校(医学教育部医学科進学課程及び専門課程、動物実験施設、共同利用研究施設、病院並びに防衛, 外科学, 講師 2018 – 2019: 防衛医科大学校(医学教育部医学科進学課程及び専門課程、動物実験施設、共同利用研究施設、病院並びに防衛, 外科学, 助教
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related Except Principal Investigator Medium-sized Section 58:Society medicine, nursing, and related fields
Keywords	Principal Investigator CA125 / 抗体治療 / 膵癌 / Mesothelin Except Principal Investigator 包括的高感度転写産物プロファイリング法 / 高感度発現解析 / 次世代シーケンシング / 包括的高感度転写産物プロファイリング / 腎細胞癌 / 浸潤性膵管癌

Development of a diagnostic technique using novel high-sensitivity expression analyses for secondary prevention against pancreatic and renal tumors
- Principal Investigator
  
  Nakayama Akiyoshi
- Project Period (FY)
  2022 – 2023
- Research Category
  
  Grant-in-Aid for Challenging Research (Exploratory)
- Review Section
  
  Medium-sized Section 58:Society medicine, nursing, and related fields
- Research Institution
  National Defense Medical College
Mesothelin targeted cancer immunotherapy for patientsPrincipal Investigator
- Principal Investigator
  
  Einama Takahiro
- Project Period (FY)
  2018 – 2021
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  National Defense Medical College

All 2021 2020 2019

All Journal Article

[Journal Article] Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients2021
- Author(s)
  Einama Takahiro、Yamagishi Yoji、Takihata Yasuhiro、Suzuki Takafumi、Kobayashi Kazuki、Yonamine Naoto、Fujinuma Ibuki、Tsunenari Takazumi、Koga Makiko、Nagata Ken、Shiraishi Takehiro、Nakazawa Akiko、Shinto Eijii, Ueno Hideki、Kishi Yoji、Tsuda Hitoshi
- Journal Title
  
  Biomarker Research
  
  Volume: 9 Issue: 1
- DOI
  10.1186/s40364-021-00335-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K15295
[Journal Article] Different role of MSLN and CA125 co-expression as a prognostic predictor between perihilar and distal bile duct carcinoma2021
- Author(s)
  Takihata Yasuhiro、Einama Takahiro、Kobayashi Kazuki、Suzuki Takafumi、Yonamine Naoto、Fujinuma Ibuki、Tsunenari Takazumi、Yamagishi Yoji、Iwasaki Toshimitsu、Miyata Yoichi、Shinto Eiji、Ogata Sho、Tsujimoto Hironori、Ueno Hideki、Kishi Yoji
- Journal Title
  
  Oncology Letters
  
  Volume: 21 Issue: 5
- DOI
  10.3892/ol.2021.12675
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K15295
[Journal Article] Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells2021
- Author(s)
  Matsuzawa Fumihiko、Kamachi Hirofumi、Mizukami Tatsuzo、Einama Takahiro、Kawamata Futoshi、Fujii Yuki、Fukai Moto、Kobayashi Nozomi、Hatanaka Yutaka、Taketomi Akinobu
- Journal Title
  
  BMC Cancer
  
  Volume: 21 Issue: 1
- DOI
  10.1186/s12885-020-07722-3
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K15295
[Journal Article] Membrane mesothelin expression positivity is associated with poor clinical outcome of luminal?type breast cancer2020
- Author(s)
  Suzuki Takafumi、Yamagishi Yoji、Einama Takahiro、Koiwai Tomomi、Yamasaki Tamio?、Fukumura?koga Makiko、Ishibashi Yusuke、Takihata Yasuhiro?、Shiraishi Takehiro、Miyata Yoichi、Iwasaki Toshimitsu、Shinto Eiji、Sato Kimiya?、Ueno Hideki、Yamamoto Junji、Kishi Yoji、Tsuda Hitoshi
- Journal Title
  
  Oncology Letters
  
  Volume: 20 Issue: 5 Pages: 193-193
- DOI
  10.3892/ol.2020.12055
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K15295, KAKENHI-PROJECT-18K07340
[Journal Article] Mesothelin expression has prognostic value in stage ΙΙ/ΙΙΙ colorectal cancer.2019
- Author(s)
  Takehiro Shiraishi, Eiji Shinto, Satsuki Mochizuki, Hitoshi Tsuda, Yoshiki Kajiwara, Koichi Okamoto, Takahiro Einama, Kazuo Hase, Hideki Ueno
- Journal Title
  
  Virchows Arch
  
  Volume: 474 Issue: 3 Pages: 297-307
- DOI
  10.1007/s00428-018-02514-4
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K07052, KAKENHI-PROJECT-18K08721, KAKENHI-PROJECT-18K15295

1. Nakayama Akiyoshi (50876000)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
2. 中岡博史 (70611193)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
3. 望月早月

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
4. 上野秀樹

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Einama Takahiro 永生 高広

Research Projects

Research Products

Co-Researchers

Development of a diagnostic technique using novel high-sensitivity expression analyses for secondary prevention against pancreatic and renal tumors

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Mesothelin targeted cancer immunotherapy for patientsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Different role of MSLN and CA125 co-expression as a prognostic predictor between perihilar and distal bile duct carcinoma2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Membrane mesothelin expression positivity is associated with poor clinical outcome of luminal?type breast cancer2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Mesothelin expression has prognostic value in stage ΙΙ/ΙΙΙ colorectal cancer.2019

Author(s)

Journal Title

DOI

Data Source

Einama Takahiro 永生高広